Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 58

Results For "IP"

11192 News Found

Vascular experts establish appropriate use of IVUS in peripheral interventions
News | August 13, 2022

Vascular experts establish appropriate use of IVUS in peripheral interventions

Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions


Congenica announces partnership with Avesthagen
Digitisation | August 13, 2022

Congenica announces partnership with Avesthagen

New deal strengthens Congenica’s presence in India


IPCA Laboratories Q1 FY23 consolidated PAT higher at Rs. 143.06 Cr
News | August 11, 2022

IPCA Laboratories Q1 FY23 consolidated PAT higher at Rs. 143.06 Cr

The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.


PIB: Development of Ayush entrepreneurship
Policy | August 03, 2022

PIB: Development of Ayush entrepreneurship

Ministry of Ayush signed a MoU with Ministry of Micro, Small & Medium Enterprises (MSME) for the promotion of Ayush enterprises.


Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes
News | August 02, 2022

Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes

The two generic drugs have been launched under the brand names Jankey & Sitenali.


Cipla posts Q1FY23 consolidated PAT at Rs. 686.40 Cr
News | July 31, 2022

Cipla posts Q1FY23 consolidated PAT at Rs. 686.40 Cr

he company has reported total income of Rs. 5478.62 crores during the period ended June 30, 2022.


Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
News | July 26, 2022

Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX

The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.


Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin
News | July 25, 2022

Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin

Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.


Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy
Drug Approval | July 20, 2022

Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China


UPS Healthcare revolutionizes prioritized shipping with UPS Premier
Supply Chain | July 16, 2022

UPS Healthcare revolutionizes prioritized shipping with UPS Premier

Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products